Ligumsky H - Search Results

1

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.

Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D. Kalich-Philosoph L, et al. Among authors: ligumsky h. Sci Transl Med. 2013 May 15;5(185):185ra62. doi: 10.1126/scitranslmed.3005402. Sci Transl Med. 2013. PMID: 23677591

2

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.

Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T. Wolf I, et al. Among authors: ligumsky h. Oncogene. 2008 Nov 27;27(56):7094-105. doi: 10.1038/onc.2008.292. Epub 2008 Sep 1. Oncogene. 2008. PMID: 18762812

3

KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer.

Abramovitz L, Rubinek T, Ligumsky H, Bose S, Barshack I, Avivi C, Kaufman B, Wolf I. Abramovitz L, et al. Among authors: ligumsky h. Clin Cancer Res. 2011 Jul 1;17(13):4254-66. doi: 10.1158/1078-0432.CCR-10-2749. Epub 2011 May 13. Clin Cancer Res. 2011. PMID: 21571866

4

The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.

Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T. Ligumsky H, et al. Breast Cancer Res Treat. 2012 Apr;132(2):449-61. doi: 10.1007/s10549-011-1585-0. Epub 2011 Jun 3. Breast Cancer Res Treat. 2012. PMID: 21638053

5

Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure-Function Analysis.

Ligumsky H, Rubinek T, Merenbakh-Lamin K, Yeheskel A, Sertchook R, Shahmoon S, Aviel-Ronen S, Wolf I. Ligumsky H, et al. Mol Cancer Res. 2015 Oct;13(10):1398-407. doi: 10.1158/1541-7786.MCR-15-0141. Epub 2015 Jun 25. Mol Cancer Res. 2015. PMID: 26113466

6

The role of α-klotho in human cancer: molecular and clinical aspects.

Ligumsky H, Merenbakh-Lamin K, Keren-Khadmy N, Wolf I, Rubinek T. Ligumsky H, et al. Oncogene. 2022 Sep;41(40):4487-4497. doi: 10.1038/s41388-022-02440-5. Epub 2022 Aug 29. Oncogene. 2022. PMID: 36038662 Review.

7

[NOVEL TECHNOLOGIES AND FUTURE TRENDS IN TRANSLATIONAL RESEARCH IN ONCOLOGY].

Ligumsky H, Bar Y, Wolf I, Bar K. Ligumsky H, et al. Harefuah. 2024 Feb;163(2):102-108. Harefuah. 2024. PMID: 38431859 Hebrew.

8

Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells.

Ligumsky H, Amir S, Arbel Rubinstein T, Guion K, Scherf T, Karasik A, Wolf I, Rubinek T. Ligumsky H, et al. Med Oncol. 2024 May 6;41(6):138. doi: 10.1007/s12032-024-02390-w. Med Oncol. 2024. PMID: 38705935

9

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients.

Ligumsky H, Safadi E, Etan T, Vaknin N, Waller M, Croll A, Nikolaevski-Berlin A, Greenberg I, Halperin T, Wasserman A, Galazan L, Arber N, Wolf I. Ligumsky H, et al. J Natl Cancer Inst. 2022 Feb 7;114(2):203-209. doi: 10.1093/jnci/djab174. J Natl Cancer Inst. 2022. PMID: 34453830 Free PMC article.

10

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer.

Ligumsky H, Dor H, Etan T, Golomb I, Nikolaevski-Berlin A, Greenberg I, Halperin T, Angel Y, Henig O, Spitzer A, Slobodkin M, Wolf I; COVI3 study investigators. Ligumsky H, et al. Lancet Oncol. 2022 Feb;23(2):193-195. doi: 10.1016/S1470-2045(21)00715-4. Epub 2021 Dec 23. Lancet Oncol. 2022. PMID: 34953523 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters